As shown in Table 1, T2D patients with DKD had older ages, longer diabetic durations, higher systolic blood pressures, a higher prevalence of hypertension, higher prevalence of insulin, and statins users, higher blood urea nitrogen (BUN) levels, creatinine (Cr) levels, uric acid (UA) levels, cystatin C levels, UACR levels, lower eGFRs, and lower LDL-C/Apo B ratios (all p < 0.05) than T2D patients without DKD. This evidence concerns the gene APOB and diabetic kidney disease.